Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Red-Fleshed Apple Anthocyanin Extracts Attenuate Male Reproductive System Dysfunction Caused by Busulfan in Mice (Mouse blood plasma; UPLC-MS/MS assays)
- Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
- Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Metabolism Disorder Promotes Isoproterenol-induced Myocardial Injury in Mice with High Temperature and High Humidity and High-Fat Diet
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
- Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
- Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
- Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis
Observed in differential profiles
- Control_vs_nsPEF_7_day
- Control_vs_Busulfan_5_mg_kg_RAAE
- Control_vs_OXPA_Treatment
- Control_vs_Exercise
- G1_PBS_vs_G2_DSS
- Control_vs_Isoproterenol
- Normal_vs_Neural_Tube_Defect
- Control_vs_ZYP_High_Dose
- Male_19_days_vs_Male_1_day
- Control_0d_vs_Treatment_180d
- CIDP_patient_vs_healthy_control
- CIDP_patient_vs_healthy_control
- Control_vs_BP3_Low_Concentration
- Normal_vs_Abnormal